Rockwell Medical, Inc. (NASDAQ:RMTI) Q2 2022 Earnings Conference Call August 15, 2022 8:00 AM ET
Company Participants
Heather Hunter - SVP & Chief Affairs Officer
Mark Strobeck - President, CEO & Director
Russell Skibsted - EVP, CFO & Chief Business Officer
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald & Co.
Operator
Good morning, and welcome to Rockwell Medical's Second Quarter 2022 Results Conference Call and Webcast. Please note, this event is being recorded.
At this time, I would like to turn the conference call over to Heather Hunter, SVP and Chief Affairs Officer at Rockwell Medical. Heather please go ahead
Heather Hunter
Good morning, and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell's new President and CEO; and Russell Skibsted, Rockwell's Chief Financial Officer and Chief Business Officer. During today's call, Mark will provide an update on Rockwell's second quarter achievements as well as an overview of the company's strategy going forward. Then Russell will discuss Rockwell's financial results. After that, we will open the lines to take your questions. .
Before we begin, I would like to remind everyone that this conference call will be -- will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws including, but not limited to, the types of statements identified as forward-looking in our annual report on Form 10-K and our subsequent periodic reports filed with the SEC which are all available on our website under the Investors section. These statements are subject to risks and uncertainties that could cause actual results to differ.
Please note that these forward-looking statements reflect our opinions and expectations only as of today. Except as required by law, we specifically disclaim any obligation to update or revise these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed in or implied by such forward-looking statements are discussed in greater detail in our periodic reports filed with the SEC. A recording of this conference call will be available on Rockwell Medical's website under the Investors section.
At this time, I would like to turn the conference call over to Rockwell Medical's President and Chief Executive Officer; Dr. Mark Strobeck.
Mark Strobeck
Thank you, Heather. Good morning, everyone, and thank you for joining us for Rockwell Medical's Second Quarter 2022 Results Conference Call and Webcast. My name is Mark Strobeck, and I am pleased to be presenting to you today as Rockwell's new President and CEO.